Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Asset Utilization Ratio (2021 - 2025)

Barinthus Biotherapeutics' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.0 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 96.44% year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, down 96.44%, while the annual FY2024 figure was 0.08, 2313.59% up from the prior year.
  • Asset Utilization Ratio reached 0.0 in Q4 2025 per BRNS's latest filing, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.16 in Q4 2022 to a low of 0.0 in Q4 2021.
  • Average Asset Utilization Ratio over 5 years is 0.06, with a median of 0.05 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: soared 16323.46% in 2022, then plummeted 98.58% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then surged by 16323.46% to 0.16 in 2022, then tumbled by 97.8% to 0.0 in 2023, then soared by 2276.96% to 0.09 in 2024, then tumbled by 96.44% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for BRNS's Asset Utilization Ratio are 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.11 (Q2 2025).